Microba Life Sciences Ltd News

Microba Life Sciences Ltd: Chair, Deputy Chair and CEO Addresses to AGM

Nov 28 19:01 ET

Microba Life Sciences Ltd: Strategic transfer of Microba Research Services Unit to CMC

Oct 9 18:10 ET

Microba Life Sciences Ltd: 2024 Appendix 4G

Aug 28 19:08 ET

Microba Life Sciences Ltd: 2024 Corporate Governance Statement

Aug 28 19:08 ET

Microba Life Sciences Ltd: Q4 FY24 Quarterly Activities Report & Appendix 4C

Jul 24 19:04 ET

Microba Life Sciences Ltd: Details of Q4 FY24 Quarterly Report, Appendix 4C & Webinar

Jul 22 19:03 ET

Microba Life Sciences Ltd: Completion of Autoimmune Program with Ginkgo Bioworks

Jun 27 19:02 ET

Microba Life Sciences Ltd: Release of Securities from Voluntary Escrow

Jun 25 03:25 ET

Microba Life Sciences Ltd: Q3 FY24 Quarterly Activities Report & Appendix 4C

Apr 22 19:04 ET

Microba Life Sciences Ltd: Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar

Apr 17 19:29 ET

Microba Life Sciences Ltd: Microba Launches Investor Hub for Investor Engagement

Apr 15 19:08 ET

Microba Life Sciences Ltd: Microba receives $6.08 million R&D Tax Incentive Refund

Apr 9 21:14 ET

Microba Life Sciences Ltd: Release of Restricted Securities

Mar 25 02:59 ET

Microba Life Sciences Ltd: MetaPanel Diagnostic Test Launched with Sonic Healthcare

Mar 12 18:10 ET

Microba Life Sciences Ltd: Q2 FY24 Quarterly Investor Presentation

Jan 29 17:23 ET

Microba Life Sciences Ltd: Q2 FY24 Quarterly Activities Report & Appendix 4C

Jan 29 17:11 ET

Microba Life Sciences Ltd: Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar

Jan 28 17:09 ET

Microba Life Sciences Ltd: Release of Restricted Securities

Jan 18 16:59 ET

Microba Life Sciences Ltd: Change of Director's Interest Notice - Jacqueline Fernley

Dec 29, 2023 00:45 ET

Microba Life Sciences Ltd: Successful IBD Phase I Clinical Trial

Dec 6, 2023 17:06 ET